Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 9.71% vs 5.56% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -2.11% vs 0.37% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is -41.17% vs 8.59% in Mar 2024
Compare Balance Sheet Results of Krebs Biochem
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
21.56
6.23
15.33
246.07%
Share Warrants & Outstandings
Total Reserve
-167.80
36.74
-204.54
-556.72%
Shareholder's Funds
-146.24
42.97
-189.21
-440.33%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
161.25
30.79
130.46
423.71%
Secured Loans
0.00
30.79
-30.79
-100.00%
Unsecured Loans
161.25
0.00
161.25
0.00%
Deferred Tax Assets / Liabilities
0.00
1.40
-1.40
-100.00%
Other Long Term Liabilities
45.00
2.30
42.70
1,856.52%
Long Term Trade Payables
2.44
0.00
2.44
0.00%
Long Term Provisions
3.06
0.00
3.06
0.00%
Total Non-Current Liabilities
211.75
34.49
177.26
513.95%
Current Liabilities
Trade Payables
18.15
6.21
11.94
192.27%
Other Current Liabilities
33.63
3.40
30.23
889.12%
Short Term Borrowings
50.96
11.93
39.03
327.16%
Short Term Provisions
0.79
0.10
0.69
690.00%
Total Current Liabilities
103.53
21.64
81.89
378.42%
Total Liabilities
169.04
99.10
69.94
70.58%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
314.11
36.10
278.01
770.11%
Less: Accumulated Depreciation
168.40
15.04
153.36
1,019.68%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
145.70
21.06
124.64
591.83%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
1.24
56.48
-55.24
-97.80%
Intangible assets under development
1.85
0.00
1.85
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.05
-0.05
-100.00%
Long Term Loans & Advances
9.98
0.00
9.98
0.00%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
158.78
77.58
81.20
104.67%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
6.03
3.67
2.36
64.31%
Sundry Debtors
0.05
9.39
-9.34
-99.47%
Cash and Bank
0.14
0.63
-0.49
-77.78%
Other Current Assets
0.47
5.13
-4.66
-90.84%
Short Term Loans and Advances
3.56
2.70
0.86
31.85%
Total Current Assets
10.26
21.51
-11.25
-52.30%
Net Current Assets (Including Current Investments)
-93.27
-0.13
-93.14
-71,646.15%
Total Current Assets Excluding Current Investments
10.26
21.51
-11.25
-52.30%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
169.04
99.10
69.94
70.58%
Contingent Liabilities
8.47
1.92
6.55
341.15%
Total Debt
212.21
42.71
169.50
396.86%
Book Value per share (adjusted)
-67.83
68.94
-136.77
-198.39%
Annual - Borrowings
Borrowings 212.21 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 9.71% vs 5.56% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 45.00 Cr
in Mar 2025Figures in Cr
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 146.94 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -2.11% vs 0.37% in Mar 2024
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 10.26 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -41.17% vs 8.59% in Mar 2024






